EQS-News: Chairperson of the Supervisory Board of Nagarro SE resigns for health reasons

19.12.25 11:00 Uhr

Werte in diesem Artikel
Aktien

74,55 EUR 0,70 EUR 0,95%

EQS-News: Nagarro SE / Key word(s): Personnel
Chairperson of the Supervisory Board of Nagarro SE resigns for health reasons

19.12.2025 / 11:00 CET/CEST
The issuer is solely responsible for the content of this announcement.

Wer­bung


Munich, December 19, 2025 – The Chairperson of the Supervisory Board of Nagarro SE, Dr. Martin Enderle, has resigned from his position as a member and Chairperson of the Supervisory Board for health reasons, effective December 31, 2025. The Supervisory Board will elect a successor to Dr. Enderle as Chairperson of the Supervisory Board in the near future. In the meantime, the Deputy Chairperson, Mr. Christian Bacherl, performs the duties of the Chairperson. The Management Board will submit an application to the competent local court in due course to fill the vacant seat on the Supervisory Board.

The members of the Supervisory Board and the Management Board would like to thank Dr. Enderle for his work on the Supervisory Board and for his dedicated commitment to the company.


About Nagarro

Nagarro, a global digital engineering leader, helps clients become fluidic, innovative, digital-first companies and thus win in their markets. The company is distinguished by its entrepreneurial, agile, and global character, its CARING mindset, and its Fluidic Intelligence vision. Nagarro employs around 17,700 people in 39 countries. For more information, visit www.nagarro.com.

Wer­bung

FRA: NA9 (SDAX/TecDAX, ISIN DE000A3H2200, WKN A3H220)

For inquiries, please contact press@nagarro.com.



19.12.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language: English
Company: Nagarro SE
Baierbrunner Straße 15
81379 München
Germany
Phone: 089 / 785 000 282
E-mail: ir@nagarro.com
Internet: www.nagarro.com
ISIN: DE000A3H2200
WKN: A3H220
Indices: TecDAX, SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2249202

 
End of News EQS News Service

Wer­bung

2249202  19.12.2025 CET/CEST

Ausgewählte Hebelprodukte auf Nagarro

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Nagarro

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Nagarro SE

Wer­bung

Analysen zu Nagarro SE

DatumRatingAnalyst
27.11.2025Nagarro SE BuyJefferies & Company Inc.
17.11.2025Nagarro SE BuyWarburg Research
14.11.2025Nagarro SE BuyJefferies & Company Inc.
28.08.2025Nagarro SE BuyJefferies & Company Inc.
15.08.2025Nagarro SE BuyWarburg Research
DatumRatingAnalyst
27.11.2025Nagarro SE BuyJefferies & Company Inc.
17.11.2025Nagarro SE BuyWarburg Research
14.11.2025Nagarro SE BuyJefferies & Company Inc.
28.08.2025Nagarro SE BuyJefferies & Company Inc.
15.08.2025Nagarro SE BuyWarburg Research
DatumRatingAnalyst
14.01.2022Nagarro SE HoldJefferies & Company Inc.
15.11.2021Nagarro SE HoldJefferies & Company Inc.
12.11.2021Nagarro SE HoldJefferies & Company Inc.
08.10.2021Nagarro SE HoldJefferies & Company Inc.
21.09.2021Nagarro SE HoldWarburg Research
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Nagarro SE nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen